Multiple Myeloma
Multiple Myeloma
Advertisement
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | May 16, 2024
Misinformation or fake news can mislead patients with multiple myeloma.
Read More
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | May 14, 2024
Nurse researchers noted patients had “feelings of confusion at the time of initial diagnosis" of multiple myeloma.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 19, 2024
Although CRAB describes end-organ symptoms of multiple myeloma, it does not provide a full picture.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 8, 2024
Myeloma is a complex blood cancer that can be difficult to comprehend, especially the 2 earlier precursor disease stages.
Cecilia BrownHematology & Blood Cancer | April 8, 2024
Researchers analyzed data from more than 1 million people to determine blood cancer mortality rates from 2000-2020.
Cecilia BrownMultiple Myeloma | May 13, 2024
Age is an important prognostic factor for patients with multiple myeloma.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOMultiple Myeloma | April 4, 2024
Learn how to ask informed questions, connect patients with resources, and support shared-decision making.
Alicia Michaelsen, BSN, RN, BMTCN®Multiple Myeloma | March 29, 2024
Alicia Michaelsen, BSN, RN, BMTCN, discusses the importance of raising awareness.
Cecilia BrownMultiple Myeloma | March 18, 2024
The withdrawal comes 2 years after the FDA granted accelerated approval to the treatment.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 18, 2024
Oncology nurses must be able to quickly identify hypercalcemia because it can cause cardiac arrest or coma.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 18, 2024
Hypercalcemia is the most common oncologic emergency, which makes it critical to understand this electrolyte imbalance.
Cecilia BrownMultiple Myeloma | March 12, 2024
A new study shows why it's critical to assess patients for financial and time toxicity.
Cecilia BrownMultiple Myeloma | March 12, 2024
There is “no apparent” standard-of-care treatment regimen for these patients.
Cecilia BrownMultiple Myeloma | March 13, 2024
Learn how a team implemented professional interpretation services in an interactive, virtual pre-HSCT nutrition class.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOMultiple Myeloma | March 1, 2024
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses what the month means to her as a nurse.
Krystal Waldrup, BSN, RN, OCNNews | February 29, 2024
Learn how an institution started a standalone CAR-T cell therapy program without a pre-existing BMT program.
Cecilia BrownMultiple Myeloma | February 28, 2024
Researchers evaluated how the bispecific antibody compared to real-world physicians’ choice of therapy.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOMultiple Myeloma | March 4, 2024
Learn how treatment for the rare blood cancer has changed over the years and how to discuss the condition with patients.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | February 21, 2024
As the care team members with the most patient contact, oncology nurses must understand shared decision-making.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | February 21, 2024
As patients may be considering or receiving anti-BCMA therapy, oncology nurses need to be able to explain this target.
Advertisement
Advertisement
Advertisement